Rebecca M. Hill

Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Strategic roadmap for delivery of clinical trials in rare childhood central nervous system (CNS) tumours: a multi-stakeholder consensus.

Strategic roadmap for delivery of clinical trials in rare childhood central nervous system (CNS) tumours: a multi-stakeholder consensus.

Journal: British journal of cancer

Published: June 08, 2026

Paediatric therapeutic development workshop on medulloblastoma.

Paediatric therapeutic development workshop on medulloblastoma.

Journal: British journal of cancer

Published: December 13, 2025

The utility of long-term methylphenidate in preserving intellectual development in survivors of childhood brain tumour.

The utility of long-term methylphenidate in preserving intellectual development in survivors of childhood brain tumour.

Journal: Journal of neuro-oncology

Published: June 22, 2025

MIF-CD74 signaling drives immune modulation in medulloblastoma.

MIF-CD74 signaling drives immune modulation in medulloblastoma.

Journal: Neuro-oncology

Published: June 13, 2025

MIF-CD74 signaling drives immune modulation in medulloblastoma.

MIF-CD74 signaling drives immune modulation in medulloblastoma.

Journal: Neuro-oncology

Published: June 13, 2025

Adverse childhood and school experiences: a retrospective cross-sectional study examining their associations with health-related behaviours and mental health.

Adverse childhood and school experiences: a retrospective cross-sectional study examining their associations with health-related behaviours and mental health.

Journal: BMC public health

Published: December 07, 2024

Sodium Thiosulfate for Ototoxicity Prevention: A National Review of UK Practice.

Sodium Thiosulfate for Ototoxicity Prevention: A National Review of UK Practice.

Journal: Pediatric blood & cancer

Published: November 28, 2024

MYC-dependent upregulation of the de novo serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastoma.

MYC-dependent upregulation of the de novo serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastoma.

Journal: Neuro-oncology

Published: October 08, 2024

Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort study.

Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort study.

Journal: Neuro-oncology

Published: October 08, 2024

Examining relationships between adverse childhood experiences and coping during the cost-of-living crisis using a national cross-sectional survey in Wales, UK.

Examining relationships between adverse childhood experiences and coping during the cost-of-living crisis using a national cross-sectional survey in Wales, UK.

Journal: BMJ open

Published: May 01, 2024

Associations between adverse childhood experiences and trust in health and other information from public services, professionals and wider sources: national cross sectional survey.

Associations between adverse childhood experiences and trust in health and other information from public services, professionals and wider sources: national cross sectional survey.

Journal: BMJ public health

Published: December 21, 2023

Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification.

Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification.

Journal: Acta neuropathologica

Published: January 18, 2023

Showing 1-12 of 42

Last Updated: 09/26/2026